ReviewJournal of neuroendovascular therapy2025
NBCA: Basic Knowledge.
Review in Journal of neuroendovascular therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Prospective evaluation of uterine artery embolization using diluted NBCA-lipiodol mixture for uterine fibroids: preliminary treatment outcomes.CVIR endovascular · 2026Article
- Sequential dual-dilution N-butyl cyanoacrylate embolisation ("Nitoryu" technique) for controlled distal penetration and proximal occlusion.CVIR endovascular · 2026Article
- Periaortic inflammation after endoleak repair: a risk to watch.CVIR endovascular · 2026Article
- In Situ ThaiPharmaceuticals (Basel, Switzerland) · 2026Article
- Management of enterocutaneous (jejunocutaneous) fistulas with NBCA glue injection: A case report.Radiology case reports · 2025Article
- Endoscopic Use of N-Butyl-2-Cyanoacrylate in Refractory Pancreatic Duct Leak and Cystic Duct Leak: Is It Really a Last Resort?Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Various types of embolic substances are used in endovascular therapy, and understanding their characteristics, including shape and kinetics, is essential for proper use. Cyanoacrylate is a typical liquid embolization agent that can be applied to many cerebral neurovascular lesions. It is injected as a mixture with ethiodized oil to provide radiopacity and regulate the polymerization rate. This review describes the characteristics, action mechanisms, techniques of use, and potential pitfalls of using cyanoacrylate-ethiodized oil mixtures for embolization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.